A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. REUTERS/Tom Little//File Photo · Reuters / Reuters The company ...
However, Novo Nordisk (NYSE: NVO), a pioneer in the field, remains one of the leaders. That likely won't change anytime soon, since the Denmark-based pharmaceutical giant has an excellent pipeline.
Wegovy maker Novo Nordisk is not immune to tariffs U.S. President Donald Trump is threatening to levy on the European Union, ...
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
Bagsværd, Denmark, 27 January 2025 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament ...
Kepler Capital analyst David Evans maintained a Hold rating on Novo Nordisk (0QIU – Research Report) on February 5 and set a price target of ...
Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...
JPMorgan lowered the firm’s price target on Novo Nordisk (NVO) to DKK 1,000 from DKK 1,050 and keeps an Overweight rating on the ...
Den danske medicinalgigant Novo Nordisk har indgået et forlig i en langstrakt sag fra 2018 i den amerikanske delstat Minnesota. Forliget betyder, at Novo Nordisk er gået med til at sætte et loft over ...
Ligesom konkurrenterne Lilly og Sanofi har Novo Nordisk nu indgået et forlig i langstrakt sag fra Minnesota Tirsdag stod Novo-boss Lars Fruergaard Jørgensen skoleret i det amerikanske Senat i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback